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risks factors associated with its progression were 
critically reviewed. Randomized studies, retrospective 
studies, cohort studies, case series, and case reports 
were included in our study making it to a total of 20 
articles that were searched and 10 were finalized for 
input. While editorials, commentaries, letters to 
editors, and abstract conferences remained in 
exclusion criteria. The citations of selected articles and 
reviews were also hand-searched.
INCIDENCE OF END
The actual incidence of END is difficult to assess because 
of variable definitions of END used across different 
studies.[3-11] Considering the eight studies in table 1 and 
excluding overlapping studies, the incidence of END 
varies broadly from 9.9% to 37.5%.[3-11] However, the rate 
of prevalence of END was almost similar in the two 
studies that used the definition ∆NIHSS ≥4 (18% and 
18.9% and 20.6%).[8,12]
PREDICTORS OF END
Numerous papers have reported and proposed variable 
factors that could predict END after AIS. The risk of END 
increases with the severity of initial stroke.[13] 
Hyperglycemia, Hypoglycemia, higher or lower NIHSS, 
elevated blood pressure, history of diabetes, coronary 
artery disease, use of aspirin, and longer admission 
delays are some of the predictors reported in the 
literature.[3-6] Certain other factors like age, sex, and 
pre-stroke level of impartiality do not commonly seem 
to be substantial risk aspects for END.[14] Some studies 
reported age as one of the factors for the onset of 
END.[5]
MECHANISMS OF END
Various mechanisms have been suggested to explain 
END after AIS. They comprise of 1) recurrent stroke As 
patients with AIS are at a higher risk of re-stroke in the 
first week but recurrent strokes noticed on 
diffusion-weighted MRI scans may not always produce 
new and discrete clinical manifestations. 2) Failure of 
collateralization; Occlusion of main cerebral vessels is 
one of the utmost significant predictors of END that 
leads to distal hypoperfusion unless actual circulation 
recanalizes. The development of collateral vessels 
helps in limiting the ischemic brain damage and further 
ensures quick recovery after an AIS. Inadequate 
collaterals with the resultant metabolic significances on 
the ischemic penumbra were reported as the most 
common mechanism of END. Other mechanisms of 
END include elevated intracranial pressure, clot 
progression, cerebral edema, seizures, and 
intraparenchymal hemorrhagic transformation. 
Advancements in cerebral vascular imaging have 
delivered a pronounced understanding of their role in 
END after AIS.[3-11,14]
CAUSES OF END
A limited number of studies have described the causes 
of END. Overall, based on the studies included in this 
review, only one has discussed the other causes of END 
apart from symptomatic intracerebral hemorrhage 
(sICH). Many factors have been reported so far that 
cause END. Malignant edema has been reported as 
one of the important causes of END. The prevalence of 
14 % to 17 % was reported among all END patients 
which demonstrating -2–3% of the overall AIS 
sample.[8] Early recurrent ischemic stroke is reported 
to be an uncommon cause of END, with a prevalence of 
0.6% and 1.8% in patients of acute strokes in which 
thrombolysis was done.[15] However, it is vital to 
underline the significance of an early recurrent 
ischemic stroke as a 100% mortality rate was reported 
following ND these patients.[15] Early symptomatic 
seizures have also been reported as the cause of END. 
In a vast cohort study of AIS patients treated with 
endovascular therapy, the prevalence of early seizures 
(24h) was 3.2%.[8]
RISK FACTORS ASSOCIATED WITH END
Huang et al. [16] suggested that certain factors like 
hyperglycemia, endovascular therapy (EVT), and 
hyperuricemia may be independently associated with 
END in AIS. Out of 213 patients attended after AIS, the 
prevalence of END was found in 31.9% (n=68) of the 
patients. Multivariate analysis revealed that END was 
certainly related to the glucose level in the blood, uric 
acid level, and treatment techniques. The most 
significant finding outcome was that a higher risk of 
END occurrence is closely associated with EVT when 
compared with those patients who received intravenous 
recombinant tissue-type plasminogen activator (rt-PA). 
Heck and Brown reported a greater prevalence of 
symptomatic transformation in patients treated with 
EVT when compared with IV rt-PA.[17] Another study 
reported an END incidence of 35.2% (44 out of 125) of 
the AIS patients within seven days post-stroke who 
underwent EVT. The majority of which (86.4%; n=38) 
occurred with 72 hours.[7]
Helleberg et al. [8] reviewed numerous studies to 
observe an association between END after AIS and the 
functional level of these patients at 3 months 
post-stroke. The authors concluded that END 
measured by the change of at least 2 points in 
Scandinavian Stroke Scale (SSS) and/or NIHSS 
predicted poor short-term and long-term outcomes in 
AIS patients and reported that SSS is not inferior to 
NIHSS in measuring the END or predicting outcome in 
these patients. Many reasons for clinical deterioration 
were also reported, including vascular pathology, 
weakened physiological homeostasis, local effects, and 
biochemical disorders.[8]
Siegler et al. [6] conducted a study on 961 AIS patients 
to look for END and its association with the stroke 
etiology (as per the TOAST classification). 323 patients 
(34%) experienced END. The large artery strokes, 
particularly involving the internal carotid artery (ICA), 
had an independent three-time higher risk of END (OR: 
3.0; 95% CI, 1.4-6.6), whereas strokes of unidentified 
etiology were least often associated with END (OR= 
0.6; 95% CI 0.4-1.0).[6]
Another study reviewed the association of different 
causes of stroke, reversible and non-reversible, with 
the time of onset of END.[5] They had a cohort of 350 
patients with AIS, 71 (20.28%) of which experienced 
ND and approximately half of these patients 
experienced END within 48 hours of a stroke. The 
patients with increased severity of the stroke 
experienced END early as compared to the patients 
with milder stroke. A one-point increase in the NIHSS 
score on admission resulted in a 3.1% shorter time to 
END (p=0.0034). The authors also noted that age has 
an inverse relation to the median onset of END, even 
after adjusting for different confounders, including 
NIHSS score on admission. For each one-year increase 
in patient’s age, a shorter time of 3.9% to ND 
(p=0.0257) was reported.[5]
Malignant edema is reported as one of the causes of 
END and its incidence among all END24 patients 
ranged from 14% to 27%. Given its interval 
progression, malignant edema is expected to occur in 
later stages of END.[8] This statement would be 
supported by the reported prevalence of 6.5 % fatal 
swelling of brain in a large group of patients admitted to 
the hospital with circulation strokes.[18]Various 
mechanisms of END include elevated intracranial 
pressure, clot progression, cerebral edema, seizures, 
and hemorrhagic transformation.[14]
Deranged blood sugar levels, both hyperglycemia, and 
hypoglycemia, are associated with END. Moreover, 
hyperglycemia on admission is related to sICH after EVT 
in AIS with resultant poor outcomes. In experimental 
models, it was proposed that an acute hyperglycemia 
leads to an increase in cerebral lactate production, 
followed by brain edema, which may contribute to the 
early development of END.[19] Apart from deranged 
blood sugar levels, other factors, for instance, elevated 
blood pressure, smoking, coronary artery disease, use 
of antiplatelet agents, and admission delays are some 
of the risk factors for END. In many patients, the cause 
of END cannot be determined despite detailed 
investigations, such cases are referred to as 
unexplained End (UnEND).
Girot et al. [20] studied the AIS patients with UnEND. A 
total of 1925 AIS patients were included in the study, 
out of which 128 (6.6%) experienced UnEND. They 
noticed that AIS patients with non-modifiable aspects 
are at greater risk to experience UnEND. The main 
predictors of UnEND were reported to be pre-stroke 
modified Rankin Scale ≥2 (OR, 2.22 [95% CI, 
1.09–4.55]), initial NIHSS (OR, 0.65 [95% CI, 
0.52–0.81]), general anesthesia (OR, 2.55 [95% CI, 
1.51–4.30]), diabetes mellitus (OR, 2.17 [95% CI, 
1.32–3.56]), and elevated blood pressure (OR, 1.10 
[95% CI, 1.01–1.20]).[20]
Advances in specialized stroke care units greatly 
improve stroke care. The stroke care units categorize 
the stroke patients based on their stroke severity and 
take active measures in high-risk patients to prevent 
and manage END appropriately. Rapid initiation of 
antithrombotic therapy and EVT results in improves 
morbidity. Proper monitoring of hypotension, large 
vessel obstruction, atrial fibrillation, hyperglycemia, and 
high body temperature is crucially important to prevent 
initial neurological deterioration and to improve the 
patient outcome.
FUTURE DIRECTIONS
END is more common than previously thought in AIS 
patients. To establish the exact incidence and 
prevalence of END, the global stroke community should 
uniformly decide and implement a widely acceptable 
definition of END. This will help in promoting the END 
research and in comparison, of the different studies to 
evaluate the risk factors of END and the crucial steps to 
prevent and manage it. Since stroke is one of the 
leading causes of morbidity and mortality in adults, the 
knowledge, prevention, and management of END along 
with the establishment of ubiquitous stroke care units 
will significantly improve the stroke outcome.
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INTRODUCTION
Acute ischemic stroke (AIS) is one of the leading 
causes of morbidity and mortality in adults.[1] AIS may 
be followed by neurological deterioration (ND) during 
the first 24-72 hours, also known as clinical worsening, 
progressive stroke, or stroke in evolution. Although 
various definitions of ND have been used across 
different studies, a more practical definition of the ND 
is an increase of 4 points in the National Institutes of 
Health Stroke Scale (NIHSS) in major acute stroke or 2 
points in NIHSS in minor stroke admitted within 24 
hours of stroke onset.[2,3] The incidence of ND may rise 
to 40% of AIS patients during hospitalization and is 
associated with both short-term and long-term 
neurologic and functional debility.[4] Multiple risk factors 
have been investigated to predict this progression in 
AIS patients, which comprise of preliminary 
assessment of stroke severity, blood pressure changes, 
brainstem infarction, hypoglycemia, hyperglycemia, 
atrial fibrillation, cardiac arrest, and diabetes mellitus 
(DM).[5,6] We categorized ND into early neurological 
deterioration (END), which occurs within 24 hours of 
AIS; and late neurological deterioration, which occurs 
within 24-72 hours of AIS, although some authors have 
defined END up to 7 days.[7] It has been noted that 
even a minor deterioration in NIHSS points has been 
related to a worse prognosis when compared to those 
patients who do not deteriorate.[6] There is limited data 
available regarding the association between stroke 
etiology and risk of ND, therefore, there is an immense 
need to evaluate the risk of ND after AIS. This concise 
review summarizes the published data from the 
literature and highlights the risk factors that influence 
the occurrence of ND in subjects with AIS.
METHODS
A detailed literature search was carried out using a 
combination of different keywords including 
“Neurological deterioration, early neurological 
deterioration, ND, END, acute stroke, acute ischemic 
stroke, and AIS” in various databases like Cochrane 
library, PubMed, Science direct, and web of science. 
Inclusion criteria were (1) Adult subjects > 18 years 
with AIS irrespective of vascular terrain or primary 
mechanism; (2) reflected END as any point of 
deterioration throughout 24 hours after hospital 
admission; and (3) studies available in the English 
language. The literature on ND following AIS and the 
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R E V I E W  A R T I C L E
risks factors associated with its progression were 
critically reviewed. Randomized studies, retrospective 
studies, cohort studies, case series, and case reports 
were included in our study making it to a total of 20 
articles that were searched and 10 were finalized for 
input. While editorials, commentaries, letters to 
editors, and abstract conferences remained in 
exclusion criteria. The citations of selected articles and 
reviews were also hand-searched.
INCIDENCE OF END
The actual incidence of END is difficult to assess because 
of variable definitions of END used across different 
studies.[3-11] Considering the eight studies in table 1 and 
excluding overlapping studies, the incidence of END 
varies broadly from 9.9% to 37.5%.[3-11] However, the rate 
of prevalence of END was almost similar in the two 
studies that used the definition ∆NIHSS ≥4 (18% and 
18.9% and 20.6%).[8,12]
PREDICTORS OF END
Numerous papers have reported and proposed variable 
factors that could predict END after AIS. The risk of END 
increases with the severity of initial stroke.[13] 
Hyperglycemia, Hypoglycemia, higher or lower NIHSS, 
elevated blood pressure, history of diabetes, coronary 
artery disease, use of aspirin, and longer admission 
delays are some of the predictors reported in the 
literature.[3-6] Certain other factors like age, sex, and 
pre-stroke level of impartiality do not commonly seem 
to be substantial risk aspects for END.[14] Some studies 
reported age as one of the factors for the onset of 
END.[5]
MECHANISMS OF END
Various mechanisms have been suggested to explain 
END after AIS. They comprise of 1) recurrent stroke As 
patients with AIS are at a higher risk of re-stroke in the 
first week but recurrent strokes noticed on 
diffusion-weighted MRI scans may not always produce 
new and discrete clinical manifestations. 2) Failure of 
collateralization; Occlusion of main cerebral vessels is 
one of the utmost significant predictors of END that 
leads to distal hypoperfusion unless actual circulation 
recanalizes. The development of collateral vessels 
helps in limiting the ischemic brain damage and further 
ensures quick recovery after an AIS. Inadequate 
collaterals with the resultant metabolic significances on 
the ischemic penumbra were reported as the most 
common mechanism of END. Other mechanisms of 
END include elevated intracranial pressure, clot 
progression, cerebral edema, seizures, and 
intraparenchymal hemorrhagic transformation. 
Advancements in cerebral vascular imaging have 
delivered a pronounced understanding of their role in 
END after AIS.[3-11,14]
CAUSES OF END
A limited number of studies have described the causes 
of END. Overall, based on the studies included in this 
review, only one has discussed the other causes of END 
apart from symptomatic intracerebral hemorrhage 
(sICH). Many factors have been reported so far that 
cause END. Malignant edema has been reported as 
one of the important causes of END. The prevalence of 
14 % to 17 % was reported among all END patients 
which demonstrating -2–3% of the overall AIS 
sample.[8] Early recurrent ischemic stroke is reported 
to be an uncommon cause of END, with a prevalence of 
0.6% and 1.8% in patients of acute strokes in which 
thrombolysis was done.[15] However, it is vital to 
underline the significance of an early recurrent 
ischemic stroke as a 100% mortality rate was reported 
following ND these patients.[15] Early symptomatic 
seizures have also been reported as the cause of END. 
In a vast cohort study of AIS patients treated with 
endovascular therapy, the prevalence of early seizures 
(24h) was 3.2%.[8]
RISK FACTORS ASSOCIATED WITH END
Huang et al. [16] suggested that certain factors like 
hyperglycemia, endovascular therapy (EVT), and 
hyperuricemia may be independently associated with 
END in AIS. Out of 213 patients attended after AIS, the 
prevalence of END was found in 31.9% (n=68) of the 
patients. Multivariate analysis revealed that END was 
certainly related to the glucose level in the blood, uric 
acid level, and treatment techniques. The most 
significant finding outcome was that a higher risk of 
END occurrence is closely associated with EVT when 
compared with those patients who received intravenous 
recombinant tissue-type plasminogen activator (rt-PA). 
Heck and Brown reported a greater prevalence of 
symptomatic transformation in patients treated with 
EVT when compared with IV rt-PA.[17] Another study 
reported an END incidence of 35.2% (44 out of 125) of 
the AIS patients within seven days post-stroke who 
underwent EVT. The majority of which (86.4%; n=38) 
occurred with 72 hours.[7]
Helleberg et al. [8] reviewed numerous studies to 
observe an association between END after AIS and the 
functional level of these patients at 3 months 
post-stroke. The authors concluded that END 
measured by the change of at least 2 points in 
Scandinavian Stroke Scale (SSS) and/or NIHSS 
predicted poor short-term and long-term outcomes in 
AIS patients and reported that SSS is not inferior to 
NIHSS in measuring the END or predicting outcome in 
these patients. Many reasons for clinical deterioration 
were also reported, including vascular pathology, 
weakened physiological homeostasis, local effects, and 
biochemical disorders.[8]
Siegler et al. [6] conducted a study on 961 AIS patients 
to look for END and its association with the stroke 
etiology (as per the TOAST classification). 323 patients 
(34%) experienced END. The large artery strokes, 
particularly involving the internal carotid artery (ICA), 
had an independent three-time higher risk of END (OR: 
3.0; 95% CI, 1.4-6.6), whereas strokes of unidentified 
etiology were least often associated with END (OR= 
0.6; 95% CI 0.4-1.0).[6]
Another study reviewed the association of different 
causes of stroke, reversible and non-reversible, with 
the time of onset of END.[5] They had a cohort of 350 
patients with AIS, 71 (20.28%) of which experienced 
ND and approximately half of these patients 
experienced END within 48 hours of a stroke. The 
patients with increased severity of the stroke 
experienced END early as compared to the patients 
with milder stroke. A one-point increase in the NIHSS 
score on admission resulted in a 3.1% shorter time to 
END (p=0.0034). The authors also noted that age has 
an inverse relation to the median onset of END, even 
after adjusting for different confounders, including 
NIHSS score on admission. For each one-year increase 
in patient’s age, a shorter time of 3.9% to ND 
(p=0.0257) was reported.[5]
Malignant edema is reported as one of the causes of 
END and its incidence among all END24 patients 
ranged from 14% to 27%. Given its interval 
progression, malignant edema is expected to occur in 
later stages of END.[8] This statement would be 
supported by the reported prevalence of 6.5 % fatal 
swelling of brain in a large group of patients admitted to 
the hospital with circulation strokes.[18]Various 
mechanisms of END include elevated intracranial 
pressure, clot progression, cerebral edema, seizures, 
and hemorrhagic transformation.[14]
Deranged blood sugar levels, both hyperglycemia, and 
hypoglycemia, are associated with END. Moreover, 
hyperglycemia on admission is related to sICH after EVT 
in AIS with resultant poor outcomes. In experimental 
models, it was proposed that an acute hyperglycemia 
leads to an increase in cerebral lactate production, 
followed by brain edema, which may contribute to the 
early development of END.[19] Apart from deranged 
blood sugar levels, other factors, for instance, elevated 
blood pressure, smoking, coronary artery disease, use 
of antiplatelet agents, and admission delays are some 
of the risk factors for END. In many patients, the cause 
of END cannot be determined despite detailed 
investigations, such cases are referred to as 
unexplained End (UnEND).
Girot et al. [20] studied the AIS patients with UnEND. A 
total of 1925 AIS patients were included in the study, 
out of which 128 (6.6%) experienced UnEND. They 
noticed that AIS patients with non-modifiable aspects 
are at greater risk to experience UnEND. The main 
predictors of UnEND were reported to be pre-stroke 
modified Rankin Scale ≥2 (OR, 2.22 [95% CI, 
1.09–4.55]), initial NIHSS (OR, 0.65 [95% CI, 
0.52–0.81]), general anesthesia (OR, 2.55 [95% CI, 
1.51–4.30]), diabetes mellitus (OR, 2.17 [95% CI, 
1.32–3.56]), and elevated blood pressure (OR, 1.10 
[95% CI, 1.01–1.20]).[20]
Advances in specialized stroke care units greatly 
improve stroke care. The stroke care units categorize 
the stroke patients based on their stroke severity and 
take active measures in high-risk patients to prevent 
and manage END appropriately. Rapid initiation of 
antithrombotic therapy and EVT results in improves 
morbidity. Proper monitoring of hypotension, large 
vessel obstruction, atrial fibrillation, hyperglycemia, and 
high body temperature is crucially important to prevent 
initial neurological deterioration and to improve the 
patient outcome.
FUTURE DIRECTIONS
END is more common than previously thought in AIS 
patients. To establish the exact incidence and 
prevalence of END, the global stroke community should 
uniformly decide and implement a widely acceptable 
definition of END. This will help in promoting the END 
research and in comparison, of the different studies to 
evaluate the risk factors of END and the crucial steps to 
prevent and manage it. Since stroke is one of the 
leading causes of morbidity and mortality in adults, the 
knowledge, prevention, and management of END along 
with the establishment of ubiquitous stroke care units 
will significantly improve the stroke outcome.
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INTRODUCTION
Acute ischemic stroke (AIS) is one of the leading 
causes of morbidity and mortality in adults.[1] AIS may 
be followed by neurological deterioration (ND) during 
the first 24-72 hours, also known as clinical worsening, 
progressive stroke, or stroke in evolution. Although 
various definitions of ND have been used across 
different studies, a more practical definition of the ND 
is an increase of 4 points in the National Institutes of 
Health Stroke Scale (NIHSS) in major acute stroke or 2 
points in NIHSS in minor stroke admitted within 24 
hours of stroke onset.[2,3] The incidence of ND may rise 
to 40% of AIS patients during hospitalization and is 
associated with both short-term and long-term 
neurologic and functional debility.[4] Multiple risk factors 
have been investigated to predict this progression in 
AIS patients, which comprise of preliminary 
assessment of stroke severity, blood pressure changes, 
brainstem infarction, hypoglycemia, hyperglycemia, 
atrial fibrillation, cardiac arrest, and diabetes mellitus 
(DM).[5,6] We categorized ND into early neurological 
deterioration (END), which occurs within 24 hours of 
AIS; and late neurological deterioration, which occurs 
within 24-72 hours of AIS, although some authors have 
defined END up to 7 days.[7] It has been noted that 
even a minor deterioration in NIHSS points has been 
related to a worse prognosis when compared to those 
patients who do not deteriorate.[6] There is limited data 
available regarding the association between stroke 
etiology and risk of ND, therefore, there is an immense 
need to evaluate the risk of ND after AIS. This concise 
review summarizes the published data from the 
literature and highlights the risk factors that influence 
the occurrence of ND in subjects with AIS.
METHODS
A detailed literature search was carried out using a 
combination of different keywords including 
“Neurological deterioration, early neurological 
deterioration, ND, END, acute stroke, acute ischemic 
stroke, and AIS” in various databases like Cochrane 
library, PubMed, Science direct, and web of science. 
Inclusion criteria were (1) Adult subjects > 18 years 
with AIS irrespective of vascular terrain or primary 
mechanism; (2) reflected END as any point of 
deterioration throughout 24 hours after hospital 
admission; and (3) studies available in the English 
language. The literature on ND following AIS and the 
risks factors associated with its progression were 
critically reviewed. Randomized studies, retrospective 
studies, cohort studies, case series, and case reports 
were included in our study making it to a total of 20 
articles that were searched and 10 were finalized for 
input. While editorials, commentaries, letters to 
editors, and abstract conferences remained in 
exclusion criteria. The citations of selected articles and 
reviews were also hand-searched.
INCIDENCE OF END
The actual incidence of END is difficult to assess because 
of variable definitions of END used across different 
studies.[3-11] Considering the eight studies in table 1 and 
excluding overlapping studies, the incidence of END 
varies broadly from 9.9% to 37.5%.[3-11] However, the rate 
of prevalence of END was almost similar in the two 
studies that used the definition ∆NIHSS ≥4 (18% and 
18.9% and 20.6%).[8,12]
PREDICTORS OF END
Numerous papers have reported and proposed variable 
factors that could predict END after AIS. The risk of END 
increases with the severity of initial stroke.[13] 
Hyperglycemia, Hypoglycemia, higher or lower NIHSS, 
elevated blood pressure, history of diabetes, coronary 
artery disease, use of aspirin, and longer admission 
delays are some of the predictors reported in the 
literature.[3-6] Certain other factors like age, sex, and 
pre-stroke level of impartiality do not commonly seem 
to be substantial risk aspects for END.[14] Some studies 
reported age as one of the factors for the onset of 
END.[5]
MECHANISMS OF END
Various mechanisms have been suggested to explain 
END after AIS. They comprise of 1) recurrent stroke As 
patients with AIS are at a higher risk of re-stroke in the 
first week but recurrent strokes noticed on 
diffusion-weighted MRI scans may not always produce 
new and discrete clinical manifestations. 2) Failure of 
collateralization; Occlusion of main cerebral vessels is 
one of the utmost significant predictors of END that 
leads to distal hypoperfusion unless actual circulation 
recanalizes. The development of collateral vessels 
helps in limiting the ischemic brain damage and further 
ensures quick recovery after an AIS. Inadequate 
collaterals with the resultant metabolic significances on 
the ischemic penumbra were reported as the most 
common mechanism of END. Other mechanisms of 
END include elevated intracranial pressure, clot 
progression, cerebral edema, seizures, and 
intraparenchymal hemorrhagic transformation. 
Advancements in cerebral vascular imaging have 
delivered a pronounced understanding of their role in 
END after AIS.[3-11,14]
CAUSES OF END
A limited number of studies have described the causes 
of END. Overall, based on the studies included in this 
review, only one has discussed the other causes of END 
apart from symptomatic intracerebral hemorrhage 
(sICH). Many factors have been reported so far that 
cause END. Malignant edema has been reported as 
one of the important causes of END. The prevalence of 
14 % to 17 % was reported among all END patients 
which demonstrating -2–3% of the overall AIS 
sample.[8] Early recurrent ischemic stroke is reported 
to be an uncommon cause of END, with a prevalence of 
0.6% and 1.8% in patients of acute strokes in which 
thrombolysis was done.[15] However, it is vital to 
underline the significance of an early recurrent 
ischemic stroke as a 100% mortality rate was reported 
following ND these patients.[15] Early symptomatic 
seizures have also been reported as the cause of END. 
In a vast cohort study of AIS patients treated with 
endovascular therapy, the prevalence of early seizures 
(24h) was 3.2%.[8]
RISK FACTORS ASSOCIATED WITH END
Huang et al. [16] suggested that certain factors like 
hyperglycemia, endovascular therapy (EVT), and 
hyperuricemia may be independently associated with 
END in AIS. Out of 213 patients attended after AIS, the 
prevalence of END was found in 31.9% (n=68) of the 
patients. Multivariate analysis revealed that END was 
certainly related to the glucose level in the blood, uric 
acid level, and treatment techniques. The most 
significant finding outcome was that a higher risk of 
END occurrence is closely associated with EVT when 
compared with those patients who received intravenous 
recombinant tissue-type plasminogen activator (rt-PA). 
Heck and Brown reported a greater prevalence of 
symptomatic transformation in patients treated with 
EVT when compared with IV rt-PA.[17] Another study 
reported an END incidence of 35.2% (44 out of 125) of 
the AIS patients within seven days post-stroke who 
underwent EVT. The majority of which (86.4%; n=38) 
occurred with 72 hours.[7]
Helleberg et al. [8] reviewed numerous studies to 
observe an association between END after AIS and the 
functional level of these patients at 3 months 
post-stroke. The authors concluded that END 
measured by the change of at least 2 points in 
Scandinavian Stroke Scale (SSS) and/or NIHSS 
predicted poor short-term and long-term outcomes in 
AIS patients and reported that SSS is not inferior to 
NIHSS in measuring the END or predicting outcome in 
these patients. Many reasons for clinical deterioration 
were also reported, including vascular pathology, 
weakened physiological homeostasis, local effects, and 
biochemical disorders.[8]
Siegler et al. [6] conducted a study on 961 AIS patients 
to look for END and its association with the stroke 
etiology (as per the TOAST classification). 323 patients 
(34%) experienced END. The large artery strokes, 
particularly involving the internal carotid artery (ICA), 
had an independent three-time higher risk of END (OR: 
3.0; 95% CI, 1.4-6.6), whereas strokes of unidentified 
etiology were least often associated with END (OR= 
0.6; 95% CI 0.4-1.0).[6]
Another study reviewed the association of different 
causes of stroke, reversible and non-reversible, with 
the time of onset of END.[5] They had a cohort of 350 
patients with AIS, 71 (20.28%) of which experienced 
ND and approximately half of these patients 
experienced END within 48 hours of a stroke. The 
patients with increased severity of the stroke 
experienced END early as compared to the patients 
with milder stroke. A one-point increase in the NIHSS 
score on admission resulted in a 3.1% shorter time to 
END (p=0.0034). The authors also noted that age has 
an inverse relation to the median onset of END, even 
after adjusting for different confounders, including 
NIHSS score on admission. For each one-year increase 
in patient’s age, a shorter time of 3.9% to ND 
(p=0.0257) was reported.[5]
Malignant edema is reported as one of the causes of 
END and its incidence among all END24 patients 
ranged from 14% to 27%. Given its interval 
progression, malignant edema is expected to occur in 
later stages of END.[8] This statement would be 
supported by the reported prevalence of 6.5 % fatal 
swelling of brain in a large group of patients admitted to 
the hospital with circulation strokes.[18]Various 
mechanisms of END include elevated intracranial 
pressure, clot progression, cerebral edema, seizures, 
and hemorrhagic transformation.[14]
Deranged blood sugar levels, both hyperglycemia, and 
hypoglycemia, are associated with END. Moreover, 
hyperglycemia on admission is related to sICH after EVT 
in AIS with resultant poor outcomes. In experimental 
models, it was proposed that an acute hyperglycemia 
leads to an increase in cerebral lactate production, 
followed by brain edema, which may contribute to the 
early development of END.[19] Apart from deranged 
blood sugar levels, other factors, for instance, elevated 
blood pressure, smoking, coronary artery disease, use 
of antiplatelet agents, and admission delays are some 
of the risk factors for END. In many patients, the cause 
of END cannot be determined despite detailed 
investigations, such cases are referred to as 
unexplained End (UnEND).
Girot et al. [20] studied the AIS patients with UnEND. A 
total of 1925 AIS patients were included in the study, 
out of which 128 (6.6%) experienced UnEND. They 
noticed that AIS patients with non-modifiable aspects 
are at greater risk to experience UnEND. The main 
predictors of UnEND were reported to be pre-stroke 
modified Rankin Scale ≥2 (OR, 2.22 [95% CI, 
1.09–4.55]), initial NIHSS (OR, 0.65 [95% CI, 
0.52–0.81]), general anesthesia (OR, 2.55 [95% CI, 
1.51–4.30]), diabetes mellitus (OR, 2.17 [95% CI, 
1.32–3.56]), and elevated blood pressure (OR, 1.10 
[95% CI, 1.01–1.20]).[20]
Advances in specialized stroke care units greatly 
improve stroke care. The stroke care units categorize 
the stroke patients based on their stroke severity and 
take active measures in high-risk patients to prevent 
and manage END appropriately. Rapid initiation of 
antithrombotic therapy and EVT results in improves 
morbidity. Proper monitoring of hypotension, large 
vessel obstruction, atrial fibrillation, hyperglycemia, and 
high body temperature is crucially important to prevent 
initial neurological deterioration and to improve the 
patient outcome.
FUTURE DIRECTIONS
END is more common than previously thought in AIS 
patients. To establish the exact incidence and 
prevalence of END, the global stroke community should 
uniformly decide and implement a widely acceptable 
definition of END. This will help in promoting the END 
research and in comparison, of the different studies to 
evaluate the risk factors of END and the crucial steps to 
prevent and manage it. Since stroke is one of the 
leading causes of morbidity and mortality in adults, the 
knowledge, prevention, and management of END along 
with the establishment of ubiquitous stroke care units 
will significantly improve the stroke outcome.
`
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INTRODUCTION
Acute ischemic stroke (AIS) is one of the leading 
causes of morbidity and mortality in adults.[1] AIS may 
be followed by neurological deterioration (ND) during 
the first 24-72 hours, also known as clinical worsening, 
progressive stroke, or stroke in evolution. Although 
various definitions of ND have been used across 
different studies, a more practical definition of the ND 
is an increase of 4 points in the National Institutes of 
Health Stroke Scale (NIHSS) in major acute stroke or 2 
points in NIHSS in minor stroke admitted within 24 
hours of stroke onset.[2,3] The incidence of ND may rise 
to 40% of AIS patients during hospitalization and is 
associated with both short-term and long-term 
neurologic and functional debility.[4] Multiple risk factors 
have been investigated to predict this progression in 
AIS patients, which comprise of preliminary 
assessment of stroke severity, blood pressure changes, 
brainstem infarction, hypoglycemia, hyperglycemia, 
atrial fibrillation, cardiac arrest, and diabetes mellitus 
(DM).[5,6] We categorized ND into early neurological 
deterioration (END), which occurs within 24 hours of 
AIS; and late neurological deterioration, which occurs 
within 24-72 hours of AIS, although some authors have 
defined END up to 7 days.[7] It has been noted that 
even a minor deterioration in NIHSS points has been 
related to a worse prognosis when compared to those 
patients who do not deteriorate.[6] There is limited data 
available regarding the association between stroke 
etiology and risk of ND, therefore, there is an immense 
need to evaluate the risk of ND after AIS. This concise 
review summarizes the published data from the 
literature and highlights the risk factors that influence 
the occurrence of ND in subjects with AIS.
METHODS
A detailed literature search was carried out using a 
combination of different keywords including 
“Neurological deterioration, early neurological 
deterioration, ND, END, acute stroke, acute ischemic 
stroke, and AIS” in various databases like Cochrane 
library, PubMed, Science direct, and web of science. 
Inclusion criteria were (1) Adult subjects > 18 years 
with AIS irrespective of vascular terrain or primary 
mechanism; (2) reflected END as any point of 
deterioration throughout 24 hours after hospital 
admission; and (3) studies available in the English 
language. The literature on ND following AIS and the 
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